Publications by authors named "Rule Sa"

Claim this Profile
S
Single-Cell Transcriptomic Analysis Reveals an Inflammatory Antigen-Presenting Macrophages Subtype Drive Vitiligo Pathogenesis Through STAT1-Mediated Dual Mechanisms.
Ruozhou Qi, Min Huang, Ziyi Lin, Huanhuan Deng, Rule Sa

Mediators Inflamm· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unveiling the genetic link and pathogenesis between psoriasis and IgA nephropathy based on Mendelian randomization and transcriptome data analyses.
Yingwen Chen, Min Huang, Ziqing You, Rule Sa, Lu Zhao

Arch Dermatol Res· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1b study of tirabrutinib in combination with idelalisib or entospletinib in previously treated B-cell lymphoma.
Franck Morschhauser, Martin J S Dyer, Harriet S Walter, Alexey V Danilov, Loic Ysebaert, Gilles Salles

Leukemia· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase Ib Study of Tirabrutinib in Combination with Idelalisib or Entospletinib in Previously Treated Chronic Lymphocytic Leukemia.
Alexey V Danilov, Charles Herbaux, Harriet S Walter, Peter Hillmen, Simon A Rule

Clin Cancer Res· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term follow-up of patients with mantle cell lymphoma (MCL) treated with the selective Bruton's tyrosine kinase inhibitor tirabrutinib (GS/ONO-4059).
Simon A Rule, Guillaume Cartron, Christopher Fegan, Franck Morschhauser, Lingling Han, Gilles Salles

Leukemia· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
On-Target Pharmacodynamic Activity of the PI3K Inhibitor Copanlisib in Paired Biopsies from Patients with Malignant Lymphoma and Advanced Solid Tumors.
Franck Morschhauser, Jean-Pascal Machiels, Gilles Salles, Sylvie Rottey, Simon A J Rule, Isabelle Genvresse, Susanne Reschke

Mol Cancer Ther· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ibrutinib is a safe and effective therapy for systemic mantle cell lymphoma with central nervous system involvement - a multi-centre case series from the United Kingdom.
David L Tucker, Georgina Naylor, Anton Kruger, Malcolm S Hamilton, George Follows

Br J Haematol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term follow-up of patients with CLL treated with the selective Bruton's tyrosine kinase inhibitor ONO/GS-4059.
Harriet S Walter, Sandrine Jayne, Simon A Rule, Guillaume Cartron, Franck Morschhauser, Salvador Macip, Gilles Salles

Blood· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ibrutinib for mantle cell lymphoma.
David L Tucker, Simon A Rule

Future Oncol· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1 clinical trial of the selective BTK inhibitor ONO/GS-4059 in relapsed and refractory mature B-cell malignancies.
Harriet S Walter, Simon A Rule, Martin J S Dyer, Lionel Karlin, Ceri Jones, Akihisa Nishimura, Gilles Salles

Blood· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A critical appraisal of ibrutinib in the treatment of mantle cell lymphoma and chronic lymphocytic leukemia.
David L Tucker, Simon A Rule

Ther Clin Risk Manag· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does transcutaneous electrical nerve stimulation (TENS) alleviate the pain experienced during bone marrow sampling in addition to standard techniques? A randomised, double-blinded, controlled trial.
David L Tucker, Mark Rockett, Mehedi Hasan, Sarah Poplar, Simon A Rule

J Clin Pathol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-agent lenalidomide in relapsed/refractory mantle cell lymphoma: results from a UK phase II study suggest activity and possible gender differences.
Heather E Eve, Sean Carey, Sarah J Richardson, Carla C Heise, Vidya Mamidipudi

Br J Haematol· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Indolent mantle-cell lymphoma: immunoglobulin variable region heavy chain sequence analysis reveals evidence of disease 10 years prior to symptomatic clinical presentation.
Simon A J Rule, Sarah Poplar, Paul A S Evans, Sheila J M O'Connor, Roger G Owen

J Clin Oncol· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenalidomide-induced tumour flare reaction in mantle cell lymphoma.
Heather E Eve, Simon A J Rule

Br J Haematol· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Facilities for the treatment of adults with haematological malignancies--'Levels of Care': BCSH Haemato-Oncology Task Force 2009.
F Matthey, A Parker, S A J Rule, J Z Wimperis, K M Ardeshna

Hematology· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autoimmune haemolytic anaemia associated with mantle cell lymphoma.
Heather E Eve, Simon A J Rule

Int J Hematol· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activity of thalidomide and lenalidomide in mantle cell lymphoma.
S J Richardson, H E Eve, J A Copplestone, M J Dyer, S A J Rule

Acta Haematol· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time to treatment does not influence overall survival in newly diagnosed mantle-cell lymphoma.
Heather E Eve, Michelle V Furtado, Michael D Hamon, Simon A J Rule

J Clin Oncol· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Simplified Mantle-Cell Lymphoma International Prognostic Index predicts overall survival but not progression-free survival in patients with mantle-cell lymphoma treated with fludarabine and cyclophosphamide +/- rituximab: results of a randomized phase II trial.
Heather E Eve, Jo Gambell, Paul Smith, Wendi Qian, Simon A J Rule

Leuk Lymphoma· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impairment of peripheral blood stem-cell mobilisation in patients with mantle-cell lymphoma following primary treatment with fludarabine and cyclophosphamide +/- rituximab.
Heather E Eve, John F Seymour, Simon A J Rule

Leuk Lymphoma· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemotherapy in the community: what do patients want?
E Pace, S Dennison, J Morris, A Barton, C Pritchard

Eur J Cancer Care (Engl)· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toxicity of fludarabine and cyclophosphamide with or without rituximab as initial therapy for patients with previously untreated mantle cell lymphoma: results of a randomised phase II study.
Heather E Eve, David Linch, Wendi Qian, Moira Ross, John F Seymour

Leuk Lymphoma· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiac involvement with mycosis fungoides: could this explain alemtuzumab toxicity?
Kerry Ann Sleigh, Mark E F Smith, Simon A J Rule

Leuk Lymphoma· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physiological doses of cannabinoids do not adversely affect MCL viability.
Sarah J Richardson, Mathieu Widmer, John Zajicek, Simon A Rule

Leuk Lymphoma· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis